Sveikatal, Inc.

16/08/2017

An overview of the scientific foundations of Sveikatal, Inc.

Lorraine Gudas investigates the irrefutable pharmacological potential of retinoids for treating cancers, diabetes, and other disorders.

23/06/2017

Vitamin A Deficiency Could Damage Beta Cells Insulin Secretion Leading To Type 2 Diabetes: more evidence in support of our strategy.

01/04/2017

We have been granted a US patent for our therapy for Type 2 Diabetes and associated disorder: "Methods of Treating Diseases Associated with a High Fat Diet and Vitamin A Deficiency using Retinoic Acid Receptor Agonists."

16/11/2016

We just won second place in the national competition.

12/10/2016

Sveikatal won first place !

11/07/2016

FDA approves topical use of a retinoid drug/

The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older.

01/07/2016

Vitamin A is an essential nutrient !
The letter asks Greenpeace to cease its efforts to block introduction of a genetically engineered strain of rice that supporters say could reduce Vitamin-A deficiencies causing blindness and death in children in the developing world.

It's the latest sign of a rift between the scientific establishment and anti-GMO activists.

22/06/2016

We recently published data a specific group of drugs that act like retinoids (RARβ2 agonists) can reverse fatty liver disease and that RARβ2 (a retinoid receptor) is an attractive target for development
of NAFLD therapies.
Key messages of the paper include:
• Hepatic stellate cells (HSCs) are an important pharmacological target for the prevention of nonalcoholic fatty liver diseases (NAFLD). • Retinoids and retinoic acid receptors (RARs) possess favorable metabolic modulating properties. • An agonist for retinoic acid receptor-β2 (RARβ2), but not RARγ, mitigates HSC activation and NAFLD.
J Mol Med (Berl). 2016 Jun 6

J Mol Med publishes reports describing major advances in the understanding, prevention, diagnosis, and treatment of human disease through the application of molecular biology and gene technology, a research discipline that has become known as molecular medicine.

23/12/2015

"There are no drugs to treat the disease [fatty Liver Disease], so..."
Sveikatal is developing a drug that may be a therapy for this disease.

A reader asks: Does weight loss reverse nonalcoholic fatty liver disease?

25/11/2015

The relationship of Vitamin A to obesity and type 2 diabetes: an overview or work from one of our founders.

Obesity might cause vitamin A deficiency in specific organs, a new study reported.

16/11/2015

The UN commemorates World Diabetes Day. We believe that our research is on the threshold of a novel therapeutic for Diabetes.
http://www.who.int/campaigns/world-health-day/2016/event/en/

A blood glucose test is used to check for gestational diabetes, which may appear for the first time during pregnancy. Photo: WHO/PAHO/Sebastián Oliel

03/11/2015

This is a major advance in our understanding of medical problems associated with obesity.

Obesity impairs the body's ability to use vitamin A appropriately and leads to deficiencies of the vitamin in major organs.